The EVERY Company Valuation, Funding & Investors

The EVERY Company is valued at $586M as of December 2021.

Last The EVERY Company valuation

$586M

Series C · Dec 2021

Last The EVERY Company funding round

$55M

Series D · Nov 2025

Cumulative funding The EVERY Company raised

$295M

across 6 funding rounds

Key investors in The EVERY Company

  • SOSV
  • Grosvenor Food & AgTech
  • B37 Ventures
  • McWin Partners
  • Temasek
  • IndieBio

The EVERY Company Overview

About The EVERY Company

San Francisco-based The EVERY Company is a precision fermentation producer of animal-free egg proteins. Founded in 2014, it ferments OvoVitellins, OvoYolk, and OvoAlbumins matching whole egg functionality for baking, dressings, and beverages. EVERY supplies NeatEgg to bakeries for meringues and custards, scaling to 1,000 tons yearly from its South San Francisco facility, partnering with food giants like Mars and Just.


Founded

2015

HQ

United StatesSan Francisco, CA

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Valuation

$586M (Dec 2021)

The EVERY Company Valuation

The EVERY Company is currently valued at $586M, based on its Series C in December 2021.

The $175M round was led by McWin Partners and Rage Capital, with participation from Temasek, VamosVentures, Essential Capital, Grosvenor Food & AgTech, Victor Douce and 3 other investors.

The EVERY Company valuation by funding round

The EVERY Company valuation by funding round
DateStageValuation
Dec 2021Series C$586M

The EVERY Company Funding History

The EVERY Company has raised a total of $295M across 6 funding rounds.

The EVERY Company's first fundraising round was a $2M seed round in July 2015. The most recent completed round was a $55M Series D in November 2025.

The EVERY Company funding rounds

The EVERY Company funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Nov 2025Series DMcWin Partners (lead); New Agrarian; Main Sequence Ventures; TO Ventures; Bloom8; Grosvenor Food & AgTech; SOSV; Minerva Foods$55M-The EVERY Company, a San Francisco-based biotechnology firm founded by Arturo Elizondo, pioneered precision fermentation technology to manufacture egg proteins using microbes rather than conventional chickens. The company's OvoPro egg protein ingredient is used by food and beverage manufacturers to create functional products with egg protein characteristics while avoiding animal agriculture. The EVERY Company closed its Series D funding round in November 2025 at $55 million, led by McWin Capital Partners through the McWin Food Tech Fund, with participation from Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, SOSV, and additional investors. The round was the first close of a larger fundraise, with CEO Elizondo indicating a second close was planned later in 2025. The capital is earmarked for manufacturing expansion, movement toward profitability, and broader market penetration in the $270 billion global egg market, particularly targeting the high-volume bakery segment. As of November 2025, The EVERY Company had achieved significant commercial traction, selling metric tons of products at scale to major food manufacturers and rolling out products at Walmart stores nationwide. The cumulative funding raised by the company reached $288 million to $294 million by the time of the Series D announcement.
Dec 2021Series CMcWin Partners (lead); Rage Capital (lead); Temasek; VamosVentures; Essential Capital; Grosvenor Food & AgTech; Victor Douce; SOSV; The Brkfst Club; Prosus Ventures$175M$586MThe EVERY Company, formerly Clara Foods, is a San Francisco-based food technology firm specializing in precision fermentation to produce animal-free functional proteins, particularly egg proteins like ovalbumin (OvoPro) and high-solubility proteins (OvoBoost), targeting the $270 billion egg market for applications in bakery, beverages, and more. The company aims to create a secure global food system by supplying B2B egg protein ingredients that match animal-derived functionality without relying on livestock. In December 2021, it closed an oversubscribed $175 million Series C funding round co-led by McWin Partners and Rage Capital, with participation from investors including Prosus Ventures, Temasek Holdings, SOSV, Grosvenor Food & AgTech, VamosVentures (via TO Ventures), and others, bringing cumulative funding to $233 million at the time. The Series C round, dated around 12/07/2021, valued the company at a post-money valuation of $585.54 million, with a reported price per share of $13.66. Proceeds were earmarked for aggressive expansion of its animal-free protein platform, including scaling manufacturing (with overseas production already underway), commercial sales in the US, Europe, and Asia, partnerships with major food companies like two of the world's largest to de-risk execution, and exploring additional animal proteins beyond eggs such as pepsin. At that stage, the company had de-risked key milestones: proving commercial-scale manufacturing, FDA approval for ingredients, and initial sales traction, positioning it as a plug-and-play platform compatible with large-scale fermentation operations. Investors highlighted the company's transition from proof-of-concept to commercial reality, with CEO Arturo Elizondo noting the capital would enable dominance in animal-free proteins. Later 2025 updates indicate the company had progressed to selling metric tons at scale to major food firms by its Series D. The firm continued raising capital, including a $55 million Series D in late 2025 led by McWin Capital Partners (bringing total funding over $290 million), to further expand US manufacturing, achieve profitability, and launch products nationwide including at Walmart.
Nov 2021Series AAgronomics (lead)$8M--
Apr 2019Series BIngredion (lead); Rich Products Ventures; IndieBio; Veronorte; B37 Ventures; Beyond Impact; SOSV; Hemisphere Ventures; Blue Horizon Corporation$40M-The EVERY Company (formerly Clara Foods) is a biotechnology company that develops animal-free proteins and ingredients using precision fermentation technology. The company specializes in creating functional proteins that replicate the performance of conventional eggs without relying on animal agriculture, with a focus on reducing reliance on volatile egg supply chains affected by avian flu and feed costs. In December 2021, the company closed a Series C round of $175 million co-led by McWin Capital and Rage Capital, with participation from Temasek, Grosvenor's Wheatsheaf Group, TO Ventures, and Prosus Ventures, bringing total funding to $233 million at that time. By November 2025, the company had announced a Series D funding round of $55 million led by McWin Capital Partners, which brought cumulative funding to $294 million. This latest round included investors such as Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, and SOSV. The company has achieved significant commercial traction, with its precision-fermented egg protein ingredients already being integrated into retail products nationwide, including a major rollout in Walmart stores across the United States. The company has demonstrated a clear path to profitability and is targeting the $270 billion global egg market, with particular focus on high-volume applications such as bakery products.
Jul 2016Series AB37 Ventures (lead); Benjamin Happ; Twynam Agricultural Group$15M--
Jul 2015SeedScott Banister; Hadi Partovi; Mission and Market; David Friedberg; SOSV; Gary Hirshberg; UpHonest Capital; Ali Partovi$2M--

Who has invested in The EVERY Company?

33 investors have backed The EVERY Company across its funding rounds, including SOSV, Grosvenor Food & AgTech, B37 Ventures, McWin Partners, Temasek and IndieBio.

Lead investors include McWin Partners, Rage Capital, Agronomics, Ingredion and B37 Ventures.


The EVERY Company Investors

Investors in The EVERY Company by funding rounds participated
InvestorHQRoundsRoleFirst check
SOSVUnited StatesPrinceton, NJ4ParticipantJul 2015
B37 VenturesUnited StatesSan Francisco, CA2LeadJul 2016
McWin PartnersCzech RepublicPrague2LeadDec 2021
Grosvenor Food & AgTechUnited KingdomLondon2ParticipantDec 2021
TemasekSingaporeSingapore1ParticipantDec 2021
New AgrarianUnited KingdomDouglas1ParticipantNov 2025
Rich Products VenturesUnited StatesBuffalo, NY1ParticipantApr 2019
Scott BanisterUnited StatesSan Francisco, CA1ParticipantJul 2015
IndieBioUnited StatesSan Francisco, CA1ParticipantApr 2019
VamosVenturesUnited StatesLos Angeles, CA1ParticipantDec 2021
VeronorteColombiaMedellín1ParticipantApr 2019
Main Sequence VenturesAustraliaAustralia1ParticipantNov 2025
Rage CapitalUnited StatesNew York City, NY1LeadDec 2021

This data is available for Pro users. Sign up to see all 33 The EVERY Company investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

The EVERY Company Competitors

The EVERY Company competitors include listed companies like Anhui Huaheng, Gujarat State Fertilizers and Grupa Azoty, and private ones like Meati, Believer Meats and Remilk.

Public and private companies comparable to The EVERY Company
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
MeatiUnited StatesBoulder, COPrivate--$650M-
Believer MeatsIsraelJerusalemPrivate--$900M-
RemilkIsraelTel AvivPrivate--$325M-
Anhui HuahengChinaChinaPublicly listed$427M$56M$622M2.0x
Gujarat State FertilizersIndiaIndiaPublicly listed$1.1B$97M$633M0.4x
Grupa AzotyPolandPolandPublicly listed$3.5B($865M)$532M0.9x

The EVERY Company Public Comps

The EVERY Company is still privately-owned, but its public comps include Modern Mills, Lesieur Cristal, Cem Zeytin, Fourth Milling, Nichols, ForFarmers, Mama's Creations, SunRice, Anhui Huaheng and Rogers Sugar.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Modern Mills$279M$85M2.8x2.6x9.2x8.8x
Lesieur Cristal$582M$24M0.9x0.9x22.7x18.3x
Cem Zeytin$58M($3M)10.5x-(232.3x)-
Fourth Milling$176M$72M3.4x3.4x8.5x8.5x
Nichols$235M$40M2.0x1.9x12.0x9.7x
ForFarmers$3.6B$158M0.2x0.2x5.1x4.6x
Mama's Creations$172M$12M2.9x2.4x41.0x24.3x
SunRice$1.3B$101M0.6x0.6x7.4x8.0x

This data is available for Pro users. Sign up to see all The EVERY Company competitors and their valuation data.

Start Free Trial

Common questions about The EVERY Company

When was The EVERY Company founded?The EVERY Company was founded in 2015.
Where is The EVERY Company headquartered?The EVERY Company is headquartered in San Francisco, CA, United States.
Is The EVERY Company publicly listed?No, The EVERY Company is a private, VC-backed company.
What is The EVERY Company's valuation?The EVERY Company was last valued at $586M in its Series C in December 2021.
How much funding has The EVERY Company raised?The EVERY Company has raised $295M across 6 funding rounds.
What was The EVERY Company's last funding round?The EVERY Company's last funding round was a $55M Series D in November 2025, led by McWin Partners.
Who are The EVERY Company's investors?The EVERY Company's investors include SOSV, B37 Ventures, McWin Partners, Grosvenor Food & AgTech, Temasek, New Agrarian, Rich Products Ventures, Scott Banister, IndieBio, VamosVentures and 23 others.
Which companies are comparable to The EVERY Company?Companies comparable to The EVERY Company include Meati, Believer Meats, Remilk, Anhui Huaheng, Gujarat State Fertilizers and Grupa Azoty.

See companies similar to The EVERY Company

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial